Regeneron Pharmaceuticals (REGN) Change in Intangibles (2025)

Regeneron Pharmaceuticals (REGN) recorded quarterly Change in Intangibles of $155.0 million in Q2 2025.

Regeneron Pharmaceuticals (REGN) Change in Intangibles (2025) Analysis & Trends

Regeneron Pharmaceuticals' Change in Intangibles history runs 1 years deep, the most recent figure standing at $155.0 million for Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.96 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2025 155.00 Mn
Jun 30, 2025 155.00 Mn